Browsing Tag
ROS1-positive NSCLC
1 post
Why updated TRUST-I and TRUST-II results make IBTROZI a top contender in targeted lung cancer therapy
Nuvation Bio unveils pivotal TRUST-I and TRUST-II updates for IBTROZI in ROS1+ lung cancer, showing strong durability and brain response. Read more now.